Details for New Drug Application (NDA): 211328
✉ Email this page to a colleague
The generic ingredient in HALOETTE is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 211328
| Tradename: | HALOETTE |
| Applicant: | Dr Reddys Labs Sa |
| Ingredient: | ethinyl estradiol; etonogestrel |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | RING;VAGINAL | Strength | 0.015MG/24HR;0.12MG/24HR | ||||
| Approval Date: | Aug 5, 2022 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
